Literature DB >> 25771274

Cost-effectiveness research in neurosurgery.

Corinna C Zygourakis1, James G Kahn2.   

Abstract

Cost and value are increasingly important components of health care discussions. Despite a plethora of cost and cost-effectiveness analyses in many areas of medicine, there has been little of this type of research for neurosurgical procedures. This scarcity is vexing because this specialty represents one of the most expensive areas in medicine. This article discusses the general principles of cost-effectiveness analyses and reviews the cost- and cost-effectiveness-related research to date in neurosurgical subspecialties. The need for standardization of cost and cost-effectiveness measurement and reporting within neurosurgery is highlighted and a set of metrics for this purpose is defined.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Cost-effectiveness; Cost-utility; Neurosurgery; QALY; Spine surgery

Mesh:

Year:  2014        PMID: 25771274     DOI: 10.1016/j.nec.2014.11.008

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

Review 1.  Machine Learning in Pituitary Surgery.

Authors:  Vittorio Stumpo; Victor E Staartjes; Luca Regli; Carlo Serra
Journal:  Acta Neurochir Suppl       Date:  2022

2.  Cost-effectiveness of minimally invasive sacroiliac joint fusion.

Authors:  Daniel J Cher; Melissa A Frasco; Renée Jg Arnold; David W Polly
Journal:  Clinicoecon Outcomes Res       Date:  2015-12-18

3.  Public awareness, knowledge of availability, and willingness to use neurosurgical care services in Sub-Saharan Africa: A cross-sectional study.

Authors:  Chibuikem A Ikwuegbuenyi; Alice Umutoni; Neri Ngole Atabe Ngwene; Placide Ngoma; Arsene Daniel Nyalundja; Daniel Safari Nteranya; Tunde A Olobatoke; Oloruntoba Ogunfolaji; Dawin Sichimba; Joanitor Najjuma; Lorraine Arabang Sebopelo; Aliyu Ndajiwo; Michael A Bamimore; Gideon Adegboyega; Ulrick Sidney Kanmounye
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.